ATR-258 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Feb 2026: Trial registered, NCT07421024
  2. 19 Feb 2026: Trial started, NCT07421024

The trials

NCT07421024: GRK-Biased Activation Via β2-Adrenergic Receptors in Human Skeletal Muscle

State
Under way
Phase
Phase 2
People
13 taking part
Started
19 Feb 2026
Primary completion
31 Dec 2026
Arms
ATR-258
Results
None posted
  1. 19 Feb 2026: Trial registered
  2. 19 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.